Results
Anthem Biosciences FY26 Revenue Hits ₹2,124 Crores
Anthem Biosciences reported strong FY26 results with consolidated revenue of ₹2,280 crores (18% YoY growth) and PAT of ₹592 crores (31% growth).
The CRDMO business contributed 83% of revenue at ₹1,773
